Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider TransactionsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Date Name Title Type Shares Traded Price Range
Jul 9, 2014 maida anthony e iii Director Disposition (Non Open Market) 16,534 8.26
Jul 9, 2014 maida anthony e iii Director Option Execute 20,000 6.05
Jun 27, 2014 cohen raymond w Director Acquisition (Non Open Market) 10,000 n/a
Jun 27, 2014 gagnon gilles Director Acquisition (Non Open Market) 10,000 n/a
Jun 27, 2014 krassner stuart mitchell Director Acquisition (Non Open Market) 10,000 n/a
Jun 27, 2014 krassner stuart mitchell Director Disposition (Non Open Market) 625 7.94
Jun 27, 2014 lenaz luigi md Director Acquisition (Non Open Market) 10,000 n/a
Jun 27, 2014 lenaz luigi md Director Disposition (Non Open Market) 625 7.94
Jun 27, 2014 maida anthony e iii Director Acquisition (Non Open Market) 10,000 n/a
Jun 27, 2014 maida anthony e iii Director Disposition (Non Open Market) 881 7.94
Jun 27, 2014 vyas dolatrai Director Acquisition (Non Open Market) 10,000 n/a
Jun 27, 2014 vyas dolatrai Director Disposition (Non Open Market) 793 7.94
Jun 13, 2014 krassner stuart mitchell Director Disposition (Non Open Market) 1,250 8.42
Jun 13, 2014 lenaz luigi md Director Disposition (Non Open Market) 1,250 8.42
Jun 13, 2014 maida anthony e iii Director Disposition (Non Open Market) 1,762 8.42
Jun 13, 2014 shrotriya rajesh c md Officer Disposition (Non Open Market) 16,780 8.42
Jun 13, 2014 vyas dolatrai Director Disposition (Non Open Market) 1,585 8.42
Jun 3, 2014 gustafson kurt a Officer Disposition (Non Open Market) 10,037 7.73
May 8, 2014 allen lee f md phd Officer Acquisition (Non Open Market) 20,000 n/a
Apr 17, 2014 turgeon joseph w. Officer Acquisition (Non Open Market) 120,000 n/a
Showing 1-20 of 160 transactions Page: 1 2 3 4 5 6 7 8  See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
8.20
Change:
+ 0.18
Day High:
8.23
Day Low:
8.04
Volume:
270,800
1:23 PM ET on Sep 18, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company